EXACT THERAPEUTICS AS PROVIDES STRATEGIC BUSINESS UPDATE

Plans to recommence enrolment in the ACTIVATE clinical trial and new trial in pancreatic cancer in the US.

OSLO/LONDON: 18 NOVEMBER, 2021: Exact Therapeutics AS (“EXACT-Tx”, or “the Company” Euronext Growth: EXTX), a clinical-stage precision health company evaluating Acoustic Cluster Therapy (ACT®) across multiple therapeutic areas, today announces a number of strategic, operational and scientific developments.

Read more…

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH